97
Views
0
CrossRef citations to date
0
Altmetric
Clinical Features - Review

Disease or adaptation: another look at the practice of medicine

&
Pages 239-243 | Received 20 Sep 2017, Accepted 24 Jan 2018, Published online: 02 Feb 2018

References

  • Horl WH. Anaemia management and mortality risk in chronic kidney disease. Nat Rev Nephrol. 2013;9:291–301.
  • Singh AK, Szczech L, Tang KL, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355:2085–2098.
  • Pfeffer MA, Greaves SC, Arnold JM, et al. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial. Circulation. 1997;95:2643–2651.
  • Swedberg K, Held P, Kjekshus J, et al. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med. 1992;327:678–684.
  • Friedell ML, Van Way CW 3rd, Freyberg RW, et al. Beta-blockade and operative mortality in noncardiac surgery: harmful or helpful? JAMA Surg. 2015;150:658–663.
  • van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–1367.
  • Rusavy Z, Macdonald IA, Sramek V, et al. Influences on glucose metabolism in sepsis during hyperinsulinemic clamp. J Parenteral Enteral Nutr. 2005;29:171–175.
  • Rusavy Z, Sramek V, Lacigova S, et al. Influence of insulin on glucose metabolism and energy expenditure in septic patients. Critical Care. 2004;8:R213–R220.
  • Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–1297.
  • Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35:1738–1748.
  • Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449–461.
  • Sammut IA, Jayakumar J, Latif N, et al. Heat stress contributes to the enhancement of cardiac mitochondrial complex activity. Am J Pathol. 2001;158:1821–1831.
  • Appenheimer MM, Chen Q, Girard RA, et al. Impact of fever-range thermal stress on lymphocyte-endothelial adhesion and lymphocyte trafficking. Immunol Invest. 2005;34:295–323.
  • Oian P, Maltau JM. Calculated capillary hydrostatic pressure in normal pregnancy and preeclampsia. Am J Obstet Gynecol. 1987;157:102–106.
  • Rockwell LC, Pillai S, Olson CE, et al. Inhibition of vascular endothelial growth factor/vascular permeability factor action blocks estrogen-induced uterine edema and implantation in rodents. Biol Reprod. 2002;67:1804–1810.
  • Gosling P, Sanghera K, Dickson G. Generalized vascular permeability and pulmonary function in patients following serious trauma. J Trauma. 1994;36:477–481.
  • Soeters MR, Soeters PB. The evolutionary benefit of insulin resistance. Clinical Nutrition. 2012;31:1002–1007.
  • Mikaeloff Y, Kezouh A, Suissa S. Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease. Br J Clin Pharmacol. 2008;65(2):203–209.
  • Pountos I, Georgouli T, Blokhuis TJ, et al. Pharmacological agents and impairment of fracture healing: what is the evidence? Injury. 2008;39:384–394.
  • Gorissen KJ, Benning D, Berghmans T, et al. Risk of anastomotic leakage with non-steroidal anti-inflammatory drugs in colorectal surgery. Br J Surg. 2012;99:721–727.
  • Paulasir S, Kaoutzanis C, Welch KB, et al. Nonsteroidal anti-inflammatory drugs: do they increase the risk of anastomotic leaks following colorectal operations? Dis Colon Rectum. 2015;58:870–877.
  • Bhala N, Emberson J, Merhi A, et al.; Coxib, traditional NTC. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382:769–779.
  • Kahn BB, McGraw TE. Rosiglitazone, PPARgamma, and type 2 diabetes. N Engl J Med. 2010;363:2667–2669.
  • Ioannidis JP. Why most published research findings are false. PLoS Med. 2005;2:e124.
  • de Leeuw PW, Postma CT, Kroon AA. Treatment of atherosclerotic renal artery stenosis: time for a new approach. JAMA. 2013;309:663–664.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.